Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium chloride + calcium chloride + dextrose monohydrate + sodium lactate + magnesium chloride is a multi-component peritoneal dialysis solution used for renal replacement therapy in patients with renal failure requiring peritoneal dialysis. It is marketed in products such as Delflex and Dianeal. Dextrose monohydrate functions as the osmotic agent that creates a transperitoneal osmotic gradient to promote ultrafiltration and fluid removal, while sodium, calcium, magnesium, and chloride provide electrolyte content and sodium lactate serves as a metabolizable buffer that helps correct acid-base abnormalities. This product is not a targeted small molecule or biologic; its therapeutic effect is primarily physicochemical within the peritoneal cavity rather than mediated by a discrete molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium chloride + calcium chloride + dextrose monohydrate + sodium lactate + magnesium chloride.